Importantly, other studies have shown that exosomes (Exos)-derived from TRAIL-expressing MSCs reduced tumor weight in tumor-bearing mice, indicating that MSC-derived Exo-TRAIL has a prospective ability for cancer therapy (210). The gene discussed is TNFSF10; the disease is neoplasm.